University of Colorado Anschutz Cancer Center

University of Colorado Anschutz Cancer Center The official page of the University of Colorado Anschutz Cancer Center - Colorado's only National Cancer Institute-designated cancer center.

Located on the Anschutz Medical Campus, the University of Colorado Cancer Center is Colorado’s only National Cancer Institute-designated comprehensive cancer center, a distinction recognizing its outstanding contributions to research, clinical trials, prevention and cancer control. CU Cancer Center is a member of the prestigious National Comprehensive Cancer Network®, an alliance of the nation’s leading cancer centers working to establish and deliver the gold standard in cancer clinical guidelines. NCI website: http://www.cancer.gov
National Comprehensive Cancer Network Website: http://www.nccn.org

“In our clinic, a geriatrician conducts an in-depth analysis of the specific issues that people are facing, and that is ...
04/07/2026

“In our clinic, a geriatrician conducts an in-depth analysis of the specific issues that people are facing, and that is used to provide them with supportive care interventions and also to optimize the treatment according to what we know about the benefits and risks of treatments with age.”

Learn more about this new multidisciplinary clinic at UCHealth, overseen by CU Anschutz Cancer Center leader Enrique Soto Perez de Celis, MD, PhD ⬇️

A multidisciplinary clinic overseen by Enrique Soto Perez de Celis, MD, PhD, is helping older people with cancer get the help they need.

Make sure to get your raffle ticket before 5/2! All funds from this Cancer League of Colorado raffle will go to cancer r...
04/07/2026

Make sure to get your raffle ticket before 5/2! All funds from this Cancer League of Colorado raffle will go to cancer research, clinical trials, and services right here in Colorado.

You can find more information here: https://bit.ly/3PLEKRd

On Saturday, over 70 participants came together for the seventh annual Paul R. O’Hara II Esophagogastric Symposium! This...
04/06/2026

On Saturday, over 70 participants came together for the seventh annual Paul R. O’Hara II Esophagogastric Symposium! This event showcased live Q&As and informative presentations about the latest in esophageal cancer research, screening guidelines, and more. 💜

CU Anschutz Cancer Center members Heather Leach, PhD, and Rebecca Scalzo, PhD, recently published research investigating...
04/03/2026

CU Anschutz Cancer Center members Heather Leach, PhD, and Rebecca Scalzo, PhD, recently published research investigating how activity behaviors can reduce the risk of developing type 2 diabetes among breast cancer survivors taking selective estrogen receptor modulators.

Learn more about this research ⬇️

Research from Heather Leach, PhD, shows that women taking SERM drugs may reduce diabetes risk with movement breaks throughout the day.

04/03/2026

The Fitzsimons Building on University of Colorado Anschutz is lit up until 4/7 for Esophageal Cancer Awareness Month! 💜

To help honor this month, you can join us this Saturday for the Seventh Annual Paul R. O'Hara II Esophagogastric Cancer Symposium: https://bit.ly/3DOuTEN

Additionally, the Katy O. and Paul M. Rady Center of Excellence invites you to a 5K Fun Run/Walk on 4/25 to raise awareness for esophageal cancer: https://bit.ly/4cobdpt

Samuel Burciaga, a first-generation Mexican-American Immunology PhD student at the University of Colorado Anschutz, and ...
04/02/2026

Samuel Burciaga, a first-generation Mexican-American Immunology PhD student at the University of Colorado Anschutz, and his team are refining CAR-T cell therapies and related immunotherapies by exploring how immune cells can be engineered or activated to more effectively target cancer.

Learn more in this video ⬇️

Samuel Burciaga, a first-generation student pursuing his Ph.D. at CU Anschutz, is driven by a passion for advancing cancer research by enhancing the immune system’s ability to fight disease. His work focuses on developing new approaches to improve patient outcomes, including for children with

04/01/2026

April is Head and Neck Cancer Awareness Month! To kick off this month, CU Anschutz Cancer Center's Jessica McDermott, MD, raises awareness of the human papillomavirus (HPV), which has become an increasingly prevalent risk factor for head and neck cancers.

Learn more about head and neck cancers and how to prevent them: https://bit.ly/3TRmmG7

After a stage IV colorectal cancer diagnosis five years ago, Becky Grubb credits Wells Messersmith, MD, and the rest of ...
03/31/2026

After a stage IV colorectal cancer diagnosis five years ago, Becky Grubb credits Wells Messersmith, MD, and the rest of her care team at the CU Anschutz Cancer Center for being the heartbeat behind her journey.

To close out Colorectal Cancer Awareness Month, read Grubb's story ⬇️

Becky Grubb credits the CU Anschutz Cancer Center’s multidisciplinary care and clinical trials – plus a ‘huge village’ of support – for her quality of life

Thomas Flaig, MD, Vice Chancellor for Research at University of Colorado Anschutz and a member of the cancer center, con...
03/30/2026

Thomas Flaig, MD, Vice Chancellor for Research at University of Colorado Anschutz and a member of the cancer center, continues to advance bladder cancer care nationally. As chair of the National Comprehensive Cancer Network Bladder Cancer Committee, he plays a key role in shaping global treatment guidelines.

At the NCCN Annual Conference in Orlando, Flaig highlighted new therapies, real-world care strategies, and recent research, such as improved cancer monitoring and innovative treatment combinations.

Discover more about bladder cancer, our ongoing research, and clinical trials: https://medschool.cuanschutz.edu/colorado-cancer-center/for-patients-families/cancers-we-treat/bladder-cancer

03/30/2026

Today is National Doctors' Day, leave a comment celebrating your favorite oncologist! 💛 🖤

03/27/2026

Cathy Bradley, PhD, CU Anschutz Cancer Center deputy director and dean of the Colorado School of Public Health (CoSPH), shares the importance of the Colorado Cancer Screening Program (CCSP).

The leadership of the CU Anschutz Cancer Center and CoSPH support the CCSP's initiatives for underserved populations and sincerely value the partnerships it creates.

Learn more about the CSSP: https://medschool.cuanschutz.edu/colorado-cancer-center/community/CommunityOutreachEngagement/projects-and-activities/colorado-cancer-screening-program

After her uterine cancer returned, Teresa Anne Volgenau was having a tough time. But through her participation in a clin...
03/26/2026

After her uterine cancer returned, Teresa Anne Volgenau was having a tough time. But through her participation in a clinical trial studying psilocybin, she found joy and acceptance.

Learn more about Volgenau's story and this research led by Stacy Fischer, MD, co-leader of cancer prevention and control, by clicking the link in our first comment.

Address

13001 E 17th Place
Aurora, CO
80045

Alerts

Be the first to know and let us send you an email when University of Colorado Anschutz Cancer Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

Located on the Anschutz Medical Campus, the University of Colorado Cancer Center is Colorado’s only National Cancer Institute-designated comprehensive cancer center, a distinction recognizing its outstanding contributions to research, clinical trials, prevention and cancer control. CU Cancer Center is a member of the prestigious National Comprehensive Cancer Network®, an alliance of the nation’s leading cancer centers working to establish and deliver the gold standard in cancer clinical guidelines. CU Cancer Center is a consortium of more than 400 researchers and physicians at three state universities and six institutions, all working toward one goal: Translating science into life.

Mission

To discover, develop and deliver breakthroughs in diagnosis, treatment, and prevention that improve cancer care locally, nationally and globally. These efforts form the basis of a comprehensive spectrum of translational prevention, diagnosis, treatment, survivorship and outreach programs and provide a framework for training the next generation of cancer researchers and physicians.

Vision